These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5911581)

  • 1. Amethopterin resistance in clonal lines of L1210 mouse leukemia: some associated biologic and biochemical alterations.
    Hoshino A; Albrecht AM; Biedler JL; Hutchison DJ
    Cancer Res; 1966 Jul; 26(7):1397-407. PubMed ID: 5911581
    [No Abstract]   [Full Text] [Related]  

  • 2. ASSOCIATION OF INCREASED DIHYDROFOLATE REDUCTASE LEVELS AND CHROMOSOME ALTERATION IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210.
    SCHRECKER AW; VENDITTI JM; GREENBERG NH; BIEDLER JL; ROBINSON DL; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():557-74. PubMed ID: 14059003
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmacologic aspects of homofolate derivatives in relation to amethopterin-resistant murine leukemia.
    Mead JA; Goldin A; Kisliuk RL; Friedkin M; Plante L; Crawford EJ; Kwok G
    Cancer Res; 1966 Nov; 26(11):2374-9. PubMed ID: 4959533
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies with tetrahydrohomofolate and thymidylate synthetase from amethopterin-resistant mouse leukemia cells.
    Livingston D; Crawford EJ; Friedkin M
    Biochemistry; 1968 Aug; 7(8):2814-8. PubMed ID: 4875280
    [No Abstract]   [Full Text] [Related]  

  • 5. SELECTION OF CHROMOSOMAL VARIANT IN AMETHOPTERIN-RESISTANT SUBLINES OF LEUKEMIA L1210 WITH INCREASED LEVELS OF DIHYDROFOLATE REDUCTASE.
    BIEDLER JL; SCHRECKER AW; HUTCHISON DJ
    J Natl Cancer Inst; 1963 Sep; 31():575-601. PubMed ID: 14059004
    [No Abstract]   [Full Text] [Related]  

  • 6. Fate of amethopterin-resistant mutants in L1210 mouse leukemia populations.
    Hoshino A; Albrecht AM; Hutchison DJ
    Cancer Res; 1966 May; 26(5):974-8. PubMed ID: 5934806
    [No Abstract]   [Full Text] [Related]  

  • 7. On the nature of a transport alteration determining resistance to amethopterin in the L1210 leukemia.
    Sirotnak FM; Kurita S; Hutchison DJ
    Cancer Res; 1968 Jan; 28(1):75-80. PubMed ID: 5635374
    [No Abstract]   [Full Text] [Related]  

  • 8. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo.
    Sirotnak FM; Moccio DM; Kelleher LE; Goutas LJ
    Cancer Res; 1981 Nov; 41(11 Pt 1):4447-52. PubMed ID: 7306968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYTOGENETICS OF MOUSE LEUKEMIA L1210. I. ASSOCIATION OF A SPECIFIC CHROMOSOME WITH DIHYDROFOLATE REDUCTASE ACTIVITY IN AMETHOPTERIN-TREATED SUBLINES.
    BIEDLER JL; ALBRECHT AM; HUTCHISON DJ
    Cancer Res; 1965 Feb; 25():246-57. PubMed ID: 14264058
    [No Abstract]   [Full Text] [Related]  

  • 10. ON THE SIMILARITY OF DIHYDROFOLATE REDUCTASES FROM AMETHOPTERIN-SENSITIVE AND AMETHOPTERIN-RESISTANT MOUSE LEUKEMIA (L1210) CELLS.
    KASHKET ER; CRAWFORD EJ; FRIEDKIN M; HUMPHREYS SR; GOLDIN A
    Biochemistry; 1964 Dec; 3():1928-31. PubMed ID: 14269312
    [No Abstract]   [Full Text] [Related]  

  • 11. Growth of L1210 mouse leukemia cells in vitro.
    Hutchison DJ; Ittensohn OL; Bjerregaard MR
    Exp Cell Res; 1966 Apr; 42(1):157-70. PubMed ID: 5929562
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake and metabolism of N 5 -formyltetrahydrofolate by L1210 leukemia cells.
    Nahas A; Nixon PF; Bertino JR
    Cancer Res; 1972 Jul; 32(7):1416-21. PubMed ID: 5030574
    [No Abstract]   [Full Text] [Related]  

  • 13. Design and synthesis of histidine analogues of folic acid and methotrexate as potential folylpolyglutamate synthetase inhibitors.
    Mao Z; Pan J; Kalman TI
    J Med Chem; 1996 Oct; 39(21):4340-4. PubMed ID: 8863812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of perfusion with amethopterin on L1210 leukemia cells in spin filter culture.
    Thayer PS; Himmelfarb P; Roberts D
    Cancer Res; 1970 Jun; 30(6):1709-14. PubMed ID: 5457937
    [No Abstract]   [Full Text] [Related]  

  • 15. Some biochemical and pharmacologic properties of amethopterin-albumin.
    Jacobs SA; D'Urso-Scott M; Bertino JR
    Ann N Y Acad Sci; 1971 Nov; 186():284-6. PubMed ID: 5289421
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of serine metabolism by tetrahydrohomofolate in L1210 mouse leukemia cells.
    Scanlon KJ; Cashmore AR; Moroson BA; Dreyer RN; Bertino JR
    Mol Pharmacol; 1981 May; 19(3):481-90. PubMed ID: 6790934
    [No Abstract]   [Full Text] [Related]  

  • 17. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells.
    Xuan Y; Hacker MP; Tritton TR; Bhushan A
    Oncol Rep; 1998; 5(2):419-21. PubMed ID: 9468571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probenecid inhibition of methotrexate cytotoxicity in mouse L1210 leukemia cells.
    Gangji D; Ross WE; Bleyer WA; Poplack DG; Glaubiger DL
    Cancer Treat Rep; 1984 Mar; 68(3):521-5. PubMed ID: 6704981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport of the antitumor antibiotic Cl-920 into L1210 leukemia cells by the reduced folate carrier system.
    Fry DW; Besserer JA; Boritzki TJ
    Cancer Res; 1984 Aug; 44(8):3366-70. PubMed ID: 6547636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.